A naturalistic study of risperidone maintenance treatment of outpatients with severe mental illness

被引:12
作者
Megna, JL
Dewan, M
机构
[1] SUNY Hlth Sci Ctr, Dept Med, Syracuse, NY 13210 USA
[2] SUNY Hlth Sci Ctr, Dept Psychiat, Syracuse, NY 13210 USA
关键词
D O I
10.1176/ps.50.8.1084
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
In a naturalistic study of the effectiveness of atypical antipsychotics for the long-term outpatient treatment of persons with severe and persistent mental illness, 19 patients began taking risperidone and were prospectively evaluated. Nine patients dropped out of risperidone treatment before thr ee months; four of them later responded to clozapine. The ten patients who completed the study on risperidone were less severely ill at baseline. Three completers with unremitting negative symptoms required a combination of risperidone and typical antipsychotics. The results suggest that risperidone is effective for about half of patients with severe and persistent mental illness, Very ill patients who are not responsive to risperidone or combined antipsychotic therapy will likely benefit from clozapine.
引用
收藏
页码:1084 / 1086
页数:3
相关论文
共 10 条
[1]  
ADDINGTON DE, 1993, CLIN THER, V15, P917
[2]   Multiple fixed doses of ''Seroquel'' (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo [J].
Arvanitis, LA ;
Miller, BG ;
Borison, RL ;
Pitts, WM ;
Sharif, ZA ;
Hamner, MB ;
Herz, MI ;
True, JE ;
Velligan, D ;
Knesevich, MA ;
Small, J ;
Steinbook, R ;
Hertzman, M ;
Keck, PE ;
Newcomer, JW ;
Grace, J ;
Rotrosen, J ;
Tandon, R ;
Dott, SG ;
Ferguson, JM ;
Addington, DEN ;
MacEwan, GW ;
Nair, VNP ;
Shriqui, CL ;
Williams, R ;
Daniel, DG ;
Shehi, GM ;
Patterson, WM ;
Merideth, CH .
BIOLOGICAL PSYCHIATRY, 1997, 42 (04) :233-246
[3]   Olanzapine versus haloperidol: Acute phase results of the international double-blind olanzapine trial [J].
Beasley, CM ;
Hamilton, SH ;
Crawford, AM ;
Dellva, MA ;
Tollefson, GD ;
Tran, PV ;
Blin, O ;
Beuzen, JN .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1997, 7 (02) :125-137
[4]  
BRESSA GM, 1991, NEW TRENDS EXP CLIN, V7, P169
[5]  
BRIER A, 1993, HOSP COMMUNITY PSYCH, V44, P1145
[6]  
CHOUINARD G, 1993, J CLIN PSYCHOPHARM, V13, P25
[7]   IMPROVEMENT IN COGNITIVE FUNCTIONS AND PSYCHIATRIC-SYMPTOMS IN TREATMENT-REFRACTORY SCHIZOPHRENIC-PATIENTS RECEIVING CLOZAPINE [J].
HAGGER, C ;
BUCKLEY, P ;
KENNY, JT ;
FRIEDMAN, L ;
UBOGY, D ;
MELTZER, HY .
BIOLOGICAL PSYCHIATRY, 1993, 34 (10) :702-712
[8]  
KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789
[9]  
Lieberman JA, 1996, J CLIN PSYCHIAT, V57, P5
[10]  
Tollefson GD, 1997, AM J PSYCHIAT, V154, P457